Breakthroughs Blog

City of Hope has so many breakthroughs in cancer, diabetes and HIV/AIDS - and so many stories - that we've tailored our blog, Breakthroughs, to provide something for every reader. Whether the breakthroughs are about medical research, treatment advances or personal triumphs, they're all connected.

patel sunita 256x256
Sunita Patel Leads Impressive Slate of Grant Awardees

July 7, 2017 | Samantha Bonar

Sunita Patel, Ph.D., a neuropsychologist in the Population Sciences and Supportive Care Medicine departments at City of Hope, has received a $1.22 million grant from the American Cancer Society to test a new approach toward preventing long-term chemotherapy-related cognitive side effects.

Continue Reading

robert w chen md 256x256
PD-L1 inhibition is 'effective and safe' in patients with relapsed or refractory Hodgkin lymphoma

June 29, 2017 | Katie Neith

Clinical trial results in positive outcomes for patients with relapsed or treatment-resistant disease. Hodgkin lymphoma is typically considered to be one of the most curable forms of cancer, but some with the disease relapse or find that their cancer is resistant to treatment. For patients like this, a fully human monoclonal antibody called avelumab has shown promising results in a phase 1 clinical trial for safety and efficacy.

Continue Reading

Dan Rojas
Groundbreaking Stem Cell Study Ultimately Seeks a Cure for AIDS

June 20, 2017 | Samantha Bonar

Dan Rojas, 31, who has been living with HIV since 2011, is one of a handful of brave patients participating in a groundbreaking study at City of Hope that seeks a cure for AIDS.

Continue Reading

wristpedometer256x256
New Study: Tracking Surgery Patients via FitBit

June 19, 2017 | Samantha Bonar

Tracking patients using wireless wrist monitors like Fitbits is a good way to evaluate their recovery after major surgery, according to new research published in JAMA Surgery by City of Hope’s Virginia Sun, Ph.D., R.N., an assistant professor in the Division of Nursing Research and Education.

Continue Reading

Zeng-Defu
Novel Regimen May Stop Graft-Versus-Host Disease

May 4, 2017 | Katie Neith

An international team of researchers led by City of Hope’s Defu Zeng believe they may have found a way to prevent graft-versus host disease following stem cell transplants without sacrificing the transplants’ ability to fight leukemia and lymphoma.

Continue Reading

breakthroughs - behnam badie
Behnam Badie given $2.1 million R01 grant to study RAGE

May 3, 2017 | Denise Heady

What started as an unplanned lunch date has turned into a potential breakthrough in the treatment of gliomas – a fast-growing, and often deadly type of brain tumor.

Continue Reading

Mina Sedrak, M.D. - Profile Photo
New Study: Including Costs in Electronic Health Records Doesn’t Change Physician Behavior

May 1, 2017 | Letisia Marquez

A study aimed at determining whether hospitals could reduce ordering of unnecessary lab tests by displaying Medicare fees determined that price transparency does not appear to impact test orders. City of Hope’s Mina Sedrak led the study.

Continue Reading

aspirin
City of Hope study suggests aspirin may lower breast cancer risk

May 1, 2017 | Denise Heady

A daily dose of aspirin can do more than just help lower the risk of heart disease and stroke. Turns out, the benefits of aspirin can also include cancer prevention.

Continue Reading

breakthroughs - Virgina Sun
Improving Quality of Life for Ostomy Patients: A New Study

April 28, 2017 | Samantha Bonar

A new study is aimed at helping recent cancer survivors who have ostomies. The three-year randomized controlled trial is an ostomy self-management training program that hopes to coach cancer survivors to care for their ostomies via teleconferencing.

Continue Reading

Yanhong Shi and Qi
City of Hope Researchers Take Aim at Brain Cancer

April 4, 2017 | Katie Neith

Yanhong Shi, Ph.D., professor and director of the Division of Stem Cell Biology Research at Beckman Research Institute of City of Hope, believes she and colleagues have found a way to suppress the growth and self-renewal in a certain type of cancer stem cell.

Continue Reading

Load More
Back To Top